Arnold is a physician by training and a health economics & outcomes researcher with over 16 years of combined experience in clinical practice, outcomes research and pharma. He holds a medical degree from Ghana, and a dual-titled Ph.D. in Health Policy & Demography from Penn State. He is currently Director, Patient Science (Oncology) at AstraZeneca and leads clinical outcomes strategy in immuno- and targeted therapy indications for several cancers including bladder, head & neck, and prostate.